Herpes simplex virus mutations
AssigneeNorthwestern University
InventorsPatricia Spear, Sharmila Manoj, Cheryl Jogger, Dawn Myscofski, Miri Yoon
Life of this patent
Estimating the term…
Abstract
The present invention relates to compositions and methods related to mutant herpes simplex virus nucleic acid and proteins that find use in analyzing, diagnosing, and regulating viral infection.
Claims10
A composition, comprising a herpes simplex virus wherein said herpes simplex virus expresses at least one amino acid substitution selected from the group consisting of substitutions at amino acid positions 38, 215, 222, and 223 of the glycoprotein D (gD) ectodomain.
A method for eliciting an immune response in an organism, comprising:
- a) providing an organism;
- b) providing a herpes simplex virus wherein said herpes simplex virus expresses at least one amino acid substitution selected from the group consisting of substitutions at amino acid positions 38, 215, 222, and 223 of the glycoprotein D (gD) ectodomain;
- and
- c) contacting said organism with said herpes simplex virus such that said organism manifests an immune response.
A method for expressing a heterologous nucleic acid sequence in a cell, comprising:
- d) providing a cell;
- e) providing a herpes simplex virus vector wherein said herpes simplex virus vector expresses at least one amino acid substitution selected from the group consisting of substitutions at amino acid positions 27, 30, 38, 215, 222, and 223 of the glycoprotein D (gD) ectodomain;
- f) providing a heterologous nucleic acid sequence;
- and
- g) transfecting said cell with said herpes simplex virus vector containing said nucleic acid sequence such that said nucleic acid sequence is expressed in said cell.
The method of claim 8, wherein said cell is selected from the group consisting of a lymphocyte and a leukocyte.
Dependencies are inferred from the claim text.